These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2458582)

  • 1. Relationship of prostatic acid phosphatase localization in human prostate by a monoclonal antibody with the Gleason grading system.
    Sinha AA; Gleason DF; Wilson MJ; Wick MR; Reddy PK; Blackard CE
    Prostate; 1988; 13(1):1-15. PubMed ID: 2458582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of PAP and PSA gene expression in prostatic hyperplasia and prostatic carcinoma using northern-blot analyses, in situ hybridization and immunohistochemical stainings with monoclonal and bispecific antibodies.
    Hakalahti L; Vihko P; Henttu P; Autio-Harmainen H; Soini Y; Vihko R
    Int J Cancer; 1993 Oct; 55(4):590-7. PubMed ID: 7691762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical staining for DNA topoisomerase II-alpha in benign, premalignant, and malignant lesions of the prostate.
    Willman JH; Holden JA
    Prostate; 2000 Mar; 42(4):280-6. PubMed ID: 10679757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical distribution of the three predominant secretory proteins in the parenchyma of hyperplastic and neoplastic prostate glands.
    Abrahamsson PA; Lilja H; Falkmer S; Wadström LB
    Prostate; 1988; 12(1):39-46. PubMed ID: 2450341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzyme immunoassay of prostatic acid phosphatase after prostatic examination. Correlation with prostate size and immunopathology.
    el-Shirbiny AM; Shridhar P; al Adnani MS; Suresh LK
    Urology; 1988 Nov; 32(5):469-73. PubMed ID: 2460989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Creatine phosphokinase isoenzymes in human prostatic tissues: a comparison between benign hyperplasia and adenocarcinoma.
    Truong T; Carmel M; Elhilali M; Cloutier D; Lehoux JG
    Prostate; 1985; 7(2):143-9. PubMed ID: 2413430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-methylacyl-CoA racemase (P504S) expression in evolving carcinomas within benign prostatic hyperplasia and in cancers of the transition zone.
    Leav I; McNeal JE; Ho SM; Jiang Z
    Hum Pathol; 2003 Mar; 34(3):228-33. PubMed ID: 12673556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunocytochemical demonstration of prostatic acid phosphatase: different secretion kinetics between normal, hyperplastic and neoplastic prostates.
    Mori K; Wakasugi C
    J Urol; 1985 May; 133(5):877-83. PubMed ID: 2580998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of commercial immunoperoxidase kits for prostatic specific antigen and prostatic specific acid phosphatase.
    Svanholm H
    Acta Pathol Microbiol Immunol Scand A; 1986 Jan; 94(1):7-12. PubMed ID: 2421532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ratio of cathepsin B to stefin A identifies heterogeneity within Gleason histologic scores for human prostate cancer.
    Sinha AA; Quast BJ; Wilson MJ; Fernandes ET; Reddy PK; Ewing SL; Sloane BF; Gleason DF
    Prostate; 2001 Sep; 48(4):274-84. PubMed ID: 11536307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical prostatic acid phosphatase level as a prognostic factor of prostatic carcinoma.
    Sakai H; Shiraishi K; Minami Y; Yushita Y; Kanetake H; Saito Y
    Prostate; 1991; 19(3):265-72. PubMed ID: 1946042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunochemical studies of prostatic acid phosphatase.
    Choe BK; Pontes EJ; McDonald I; Rose NR
    Cancer Treat Rep; 1977; 61(2):201-4. PubMed ID: 68823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical identification of prostatic acid phosphatase: correlation of tumor grade with acid phosphatase distribution.
    Bates RJ; Chapman CM; Prout GR; Lin CW
    J Urol; 1982 Mar; 127(3):574-80. PubMed ID: 6174741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The histochemical behaviour, electrophoretic mobility and distribution in cell fractions of acid phosphatase isozymes in prostatic cancer and benign prostate hyperplasia.
    Fischer DR; Gevers W; Klerk JN; Kühn S
    Int Urol Nephrol; 1979; 11(2):111-8. PubMed ID: 89105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acid phosphatase localization in prostatic carcinoma. A comparison of monoclonal antibody to heteroantisera.
    Shevchuk MM; Romas NA; Ng PY; Tannenbaum M; Olsson CA
    Cancer; 1983 Nov; 52(9):1642-6. PubMed ID: 6193862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The significance of prostatic acid phosphatase in adenocarcinoma of the prostate.
    Bruce AW; Mahan DE; Sullivan LD; Goldenberg L
    J Urol; 1981 Mar; 125(3):357-60. PubMed ID: 6162968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical localization of prostate-specific acid phosphatase and prostate-specific antigen in stage A2 adenocarcinoma of the prostate: prognostic implications.
    Epstein JI; Eggleston JC
    Hum Pathol; 1984 Sep; 15(9):853-9. PubMed ID: 6381284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of prostatic acid phosphatase isoenzymes in normal and cancerous states.
    Lad PM; Learn DB; Cooper JF; Reisinger DM
    Clin Chim Acta; 1984 Aug; 141(1):51-65. PubMed ID: 6467620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in immunohistochemical staining of PSA, PAP, and TURP-27 following irradiation therapy for clinically localized prostate cancer.
    Grob BM; Schellhammer PF; Brassil DN; Wright GL
    Urology; 1994 Oct; 44(4):525-9. PubMed ID: 7524238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serial lectin affinity chromatography with concavalin A and wheat germ agglutinin demonstrates altered asparagine-linked sugar-chain structures of prostatic acid phosphatase in human prostate carcinoma.
    Yoshida KI; Honda M; Arai K; Hosoya Y; Moriguchi H; Sumi S; Ueda Y; Kitahara S
    J Chromatogr B Biomed Sci Appl; 1997 Aug; 695(2):439-43. PubMed ID: 9300882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.